Heparan sulfate proteoglycans of the cardiovascular system. Specific structures emerge but how is synthesis regulated?
about
Expression of heparan sulfate D-glucosaminyl 3-O-sulfotransferase isoforms reveals novel substrate specificitiesMultiple isoforms of heparan sulfate D-glucosaminyl 3-O-sulfotransferase. Isolation, characterization, and expression of human cdnas and identification of distinct genomic lociHeparan sulfate 3-O-sulfotransferase isoform 5 generates both an antithrombin-binding site and an entry receptor for herpes simplex virus, type 1Biosynthesis of dermatan sulfate: chondroitin-glucuronate C5-epimerase is identical to SART2Molecular characterization and expression of heparan-sulfate 6-sulfotransferase. Complete cDNA cloning in human and partial cloning in Chinese hamster ovary cellsCharacterization of heparan sulphate 3-O-sulphotransferase isoform 6 and its role in assisting the entry of herpes simplex virus type 1Expression of heparan sulphate L-iduronyl 2-O-sulphotransferase in human kidney 293 cells results in increased D-glucuronyl 2-O-sulphationBiosynthesis of heparan sulphate with diverse structures and functions: two alternatively spliced forms of human heparan sulphate 6-O-sulphotransferase-2 having different expression patterns and propertiesThe principal neuronal gD-type 3-O-sulfotransferases and their products in central and peripheral nervous system tissuesDistinct effects of glucose and glucosamine on vascular endothelial and smooth muscle cells: evidence for a protective role for glucosamine in atherosclerosis.Lipogenesis and lipolysis: the pathways exploited by the cancer cells to acquire fatty acidsSecreted NS1 of Dengue Virus Attaches to the Surface of Cells via Interactions with Heparan Sulfate and Chondroitin Sulfate ECrystal structure of the sulfotransferase domain of human heparan sulfate N-deacetylase/ N-sulfotransferase 1Crystal structure of beta 1,3-glucuronyltransferase I in complex with active donor substrate UDP-GlcUAThe sulfuryl transfer mechanism. Crystal structure of a vanadate complex of estrogen sulfotransferase and mutational analysisHeparan sulfate D-glucosaminyl 3-O-sulfotransferase-3A sulfates N-unsubstituted glucosamine residuesThe putative tumor suppressors EXT1 and EXT2 are glycosyltransferases required for the biosynthesis of heparan sulfateCombined strong anion-exchange HPLC and PAGE approach for the purification of heparan sulphate oligosaccharidesEndothelial cell capture of heparin-binding growth factors under flowThe occurrence of three isoforms of heparan sulfate 6-O-sulfotransferase having different specificities for hexuronic acid adjacent to the targeted N-sulfoglucosamineSynthesis of Anticoagulantly Active Heparan Sulfate Proteoglycans by Glomerular Epithelial Cells Involves Multiple 3-O-Sulfotransferase Isoforms and a Limiting Precursor PoolPreparation and characterization of (15)N-enriched, size-defined heparan sulfate precursor oligosaccharidesGenome-wide association study identifies GPC5 as a novel genetic locus protective against sudden cardiac arrest.Anticoagulant heparan sulfate precursor structures in F9 embryonal carcinoma cells.Complete antithrombin deficiency in mice results in embryonic lethality.The 1.4-Mb CMT1A duplication/HNPP deletion genomic region reveals unique genome architectural features and provides insights into the recent evolution of new genes.CS lyases: structure, activity, and applications in analysis and the treatment of diseasesEnzymatic redesigning of biologically active heparan sulfate.Extending vaterite microviscometry to ex vivo blood vessels by serial calibrationBiosynthesis of 3-O-sulfated heparan sulfate: unique substrate specificity of heparan sulfate 3-O-sulfotransferase isoform 5.Irreversible glucuronyl C5-epimerization in the biosynthesis of heparan sulfate.Molecular diversity of heparan sulfate.The heparan sulfate motif (GlcNS6S-IdoA2S)3, common in heparin, has a strict topography and is involved in cell behavior and disease.Cell surface heparan sulfate and its roles in assisting viral infections.Regulation of syndecan-4 phosphorylation in vivo.Biosynthesis of chondroitin and heparan sulfate in chinese hamster ovary cells depends on xylosyltransferase II.Normal levels of anticoagulant heparan sulfate are not essential for normal hemostasisA novel function of heparan sulfate in the regulation of cell-cell fusion.Heparin-protein interactions.Acquisition of anoikis resistance up-regulates syndecan-4 expression in endothelial cells.
P2860
Q22001454-ECCEAFAF-B3D0-4D5C-BA06-352530C061C2Q22001455-24C12E10-5F2F-40B2-A4D6-F934B709B7AEQ24302044-14545EE6-AE1C-4425-A939-0E8379F690ECQ24306073-14260C4D-94F4-4457-BB6B-1400E5208D17Q24322572-48A03481-1F3B-4891-87B3-FEB6E15A5E02Q24528151-1249870E-F2BE-4F32-AFD4-5C6A3FBC4F12Q24531959-6BC3DABC-3EBC-425E-A106-A2CCD8E6B98CQ24535653-13554CC9-AE32-4A24-8F20-A6636FD43E75Q24681471-4B97F9BD-2960-4BB8-A9E9-E66F93048322Q24813839-2FD127C0-91EB-4F2A-AD09-EF7A3150ACF5Q26996516-784A608F-1BE0-4B67-BEBB-AAC0F222DADCQ27481677-C8526C32-EC0F-46D7-8AE9-E2531F2CB2ADQ27617860-A034DF78-4878-4DC9-8665-8952C8916EFDQ27638844-8FA8A575-F244-46AA-BE7B-5DA3E15CB547Q27765678-00ED5A61-C950-4566-86D0-03DD35912F6DQ28141121-2CBEE50E-3390-40D5-B2AE-E7B0087AD345Q28284035-DD301988-1BAA-4F80-A3AB-CCDDCBAE2B83Q28348093-45735853-3693-437A-9520-33518CF757F0Q28475952-FE3C7B57-7845-47A0-B9C6-E26D9E15A930Q28594700-FA0FEC1C-0F3D-453F-AC39-1AAB022C5D15Q29041276-D0050A76-C337-4E01-994F-2ADE7AEB143BQ33615742-C54C930B-4C77-4E4F-ABD7-D9E7CDA18EC1Q33753633-CB2AE0B2-C095-449F-B1D3-E0FE480D1C17Q33852582-B024D435-70F7-4E45-9F63-F7D3D8DB253EQ33920163-7DE54AE8-BC7B-4762-885C-E239EDBAF752Q33948853-76061E89-A26A-4670-8274-936334B5661AQ33965779-78459E35-3384-448B-B308-E571E0749735Q34074988-3506852C-638F-4342-B133-3946858BCEA2Q34131288-157A6148-9A8C-4C3B-9FC4-4E4E3EDACE8CQ34220892-C1E3C1BB-913F-4629-87DE-16E544AE986DQ34289321-A891654C-63FB-4C48-9F33-0C8EE3B597F5Q34310374-B05A090F-DC39-4E29-BC11-5A3E23E9F0DEQ34412830-777BEFD7-918C-4A47-BF17-4B9DEBEF423EQ34464575-1C15157F-9C0F-429D-8913-F3AA720FF268Q34465265-4EEEE9F0-2DC8-4B01-86A4-A5C578BC4977Q34594698-240319C2-BD18-4151-AF76-E0C3C6E6F8C0Q34889931-D0098005-5669-4FB3-BC58-4B1DDBD4621EQ35000955-B2604F4D-C757-4708-B7AF-D77021721503Q35030190-859E62AB-679C-4804-B3C5-6645311BDCABQ35535743-0D8E7D08-9412-4BAA-9261-EB70E20C8C0E
P2860
Heparan sulfate proteoglycans of the cardiovascular system. Specific structures emerge but how is synthesis regulated?
description
1997 nî lūn-bûn
@nan
1997 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
Heparan sulfate proteoglycans ...... ut how is synthesis regulated?
@ast
Heparan sulfate proteoglycans ...... ut how is synthesis regulated?
@en
Heparan sulfate proteoglycans ...... ut how is synthesis regulated?
@nl
type
label
Heparan sulfate proteoglycans ...... ut how is synthesis regulated?
@ast
Heparan sulfate proteoglycans ...... ut how is synthesis regulated?
@en
Heparan sulfate proteoglycans ...... ut how is synthesis regulated?
@nl
prefLabel
Heparan sulfate proteoglycans ...... ut how is synthesis regulated?
@ast
Heparan sulfate proteoglycans ...... ut how is synthesis regulated?
@en
Heparan sulfate proteoglycans ...... ut how is synthesis regulated?
@nl
P2093
P2860
P356
P1476
Heparan sulfate proteoglycans ...... ut how is synthesis regulated?
@en
P2093
P2860
P304
P356
10.1172/JCI119377
P407
P577
1997-05-01T00:00:00Z